14-day Premium Trial Subscription Sign Up For FreeGet Free

Compugen Ltd. Stock Forecast NASDAQ:CGEN

Price Target and Analyst Ratings

Most Recent Rating

SVB Leerink is very positive about CGEN and gave it a "Buy" rating on May 18, 2021. The price target was set to $16.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-18 Buy Reiterated by SVB Leerink $8.21 $16.00
2021-04-13 Outperform Target Lowered by SVB Leerink $8.72 $19.00 → $16.00
2021-04-06 Outperform Target Lowered by SVB Leerink $8.75 $19.00 → $16.00
2021-03-17 Buy Reiterated by Oppenheimer $9.22 $19.00
2020-08-19 Outperform Target Raised by SVB Leerink $18.95 $15.00 → $19.00
2020-08-11 Buy Reiterated by Jefferies Financial Group $16.28 $20.00
2020-07-30 Buy Initiated by Oppenheimer $15.44 $19.00
2020-05-26 Outperform Initiated by JMP Securities $14.28
2020-05-13 Buy Initiated by Stifel Nicolaus $13.94 $19.00
2020-05-07 Outperform Initiated by SVB Leerink $14.33 $15.00
2020-04-28 Positive - Buy Target Raised by SunTrust Banks $13.82 $16.00 → $22.00
2020-04-27 Buy Reiterated by Oppenheimer $14.52 $15.00
2020-04-22 Buy Initiated by Roth Capital $14.72 $28.00

CGEN Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -16.74% during the next 3 months and, with a 90% probability hold a price between $4.35 and $5.60 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-30 $5.20 $5.95 $6.70
2021-10-01 $5.18 $5.93 $6.68
2021-10-04 $5.16 $5.91 $6.66
2021-10-05 $5.13 $5.89 $6.64
2021-10-06 $5.11 $5.87 $6.62
2021-10-07 $5.09 $5.84 $6.60
2021-10-08 $5.07 $5.82 $6.57
2021-10-11 $5.05 $5.80 $6.55
2021-10-12 $5.03 $5.78 $6.53
2021-10-13 $5.01 $5.76 $6.51
2021-10-14 $4.98 $5.74 $6.49
2021-10-15 $4.96 $5.72 $6.47
2021-10-18 $4.94 $5.69 $6.45
2021-10-19 $4.92 $5.67 $6.42
2021-10-20 $4.90 $5.65 $6.40
2021-10-21 $4.88 $5.63 $6.38
2021-10-22 $4.86 $5.61 $6.36
2021-10-25 $4.83 $5.59 $6.34
2021-10-26 $4.81 $5.56 $6.32
2021-10-27 $4.79 $5.54 $6.30
2021-10-28 $4.77 $5.52 $6.27
2021-10-29 $4.75 $5.50 $6.25
2021-11-01 $4.73 $5.48 $6.23
2021-11-02 $4.71 $5.46 $6.21
2021-11-03 $4.68 $5.44 $6.19
2021-11-04 $4.66 $5.41 $6.17
2021-11-05 $4.64 $5.39 $6.15
2021-11-08 $4.62 $5.37 $6.12
2021-11-09 $4.60 $5.35 $6.10
2021-11-10 $4.58 $5.33 $6.08

About Compugen Ltd.

Compugen Ltd Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company primarily focuses on immune checkpoint target candidates to serve as drug targets for cancer immunotherapies addressing various cancer types and patient populations. Its antibody drug conjugate target candidates include CGEN-15001T, CGEN-15022, CGEN-15029, CGEN-15049, C... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT